Pfizer Unusual Options Activity

Someone with a lot of money to spend has taken a bearish stance on Pfizer (NYSE:PFE). And retail…

Someone with a lot of money to spend has taken a bearish stance on Pfizer (NYSE:PFE).

And retail traders should know.

We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Whether this is an institution or just a wealthy individual, we don’t know. But when something this big happens with PFE, it often means somebody knows something is about to happen.

So how do we know what this whale just did?

Today, Benzinga‘s options scanner spotted 14 uncommon options trades for Pfizer.

This isn’t normal.

The overall sentiment of these big-money traders is split between 21% bullish and 78%, bearish.

Out of all of the special options we uncovered, 3 are puts, for a total amount of $781,800, and 11 are calls, for a total amount of $562,677.

What’s The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $20.0 to $40.0 for Pfizer over the last 3 months.

Volume & Open Interest Development

In terms of liquidity and interest, the mean open interest for Pfizer options trades today is 17981.67 with a total volume of 16,625.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for Pfizer’s big money trades within a strike price range of $20.0 to $40.0 over the last 30 days.

Pfizer Option Volume And Open Interest Over Last 30 Days

Options Call Chart

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
PFE PUT TRADE BEARISH 01/19/24 $35.00 $477.0K 41.2K 3.0K
PFE PUT TRADE NEUTRAL 09/15/23 $37.50 $268.5K 22.4K 1.7K
PFE CALL TRADE BEARISH 01/17/25 $20.00 $96.4K 947 59
PFE CALL TRADE BEARISH 01/17/25 $20.00 $79.5K 947 109
PFE CALL TRADE NEUTRAL 12/15/23 $37.50 $79.3K 60.0K 4.3K

Where Is Pfizer Standing Right Now?

  • With a volume of 10,869,375, the price of PFE is down -0.07% at $35.76.
  • RSI indicators hint that the underlying stock may be approaching overbought.
  • Next earnings are expected to be released in 56 days.

What The Experts Say On Pfizer:

  • Cantor Fitzgerald downgraded its action to Overweight with a price target of $75
  • Cantor Fitzgerald downgraded its action to Overweight with a price target of $75
  • Cantor Fitzgerald downgraded its action to Overweight with a price target of $75

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Pfizer, Benzinga Pro gives you real-time options trades alerts.

Total
0
Shares
Related Posts
Read More

Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The company said it now sees revenue of $690 million to $700 million, versus previous forecast of $670 million to $700 million.

ABM

Read More

Hoth Therapeutics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying

The Dow Jones jumped by around 197 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

BTTX